Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus.
Lloyd, Andrew
Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus. [electronic resource] - Clinical therapeutics Sep 2011 - 1258-67 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1879-114X
10.1016/j.clinthera.2011.07.017 doi
Adult
Diabetes Mellitus, Type 1--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Female
Financing, Personal
Humans
Hypoglycemic Agents--administration & dosage
Insulin, Long-Acting--administration & dosage
Male
Middle Aged
Patient Preference
Pilot Projects
Surveys and Questionnaires
Time Factors
Treatment Outcome
United Kingdom
Willingness to pay for improvements in chronic long-acting insulin therapy in individuals with type 1 or type 2 diabetes mellitus. [electronic resource] - Clinical therapeutics Sep 2011 - 1258-67 p. digital
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
1879-114X
10.1016/j.clinthera.2011.07.017 doi
Adult
Diabetes Mellitus, Type 1--drug therapy
Diabetes Mellitus, Type 2--drug therapy
Female
Financing, Personal
Humans
Hypoglycemic Agents--administration & dosage
Insulin, Long-Acting--administration & dosage
Male
Middle Aged
Patient Preference
Pilot Projects
Surveys and Questionnaires
Time Factors
Treatment Outcome
United Kingdom